In 2023 Cullgen completed a Series C financing led by AstraZeneca-CICC Venture Capital Partnership, and also announced a strategic partnership with Astellas Pharma Inc.
While this is exciting news, it will also mark the end of the game's PS5 exclusivity, which some may find disappointing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback